Business
Ph 2 Data Monitoring Committee Recommends Continuing Trial
Ph 2 Data Monitoring Committee Recommends Continuing Trial
About this update from Alterity Therapeutics Ltd.
[{"type":"text","content":"Alterity Therapeutics Ltd has released a press release. View Attachment","length":253,"tagName":"div"}]